All In MedTech

FDA Clearance Tracker · P160017-S020

MiniMed 670G System

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Dec 8, 2017 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Dec 8, 2017

Approved

Time to decision

72 days

Received Sep 27, 2017. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P160017-S020
Device name
MiniMed 670G System
Applicant location
Northridge, CA
Received
Sep 27, 2017
Decided
Dec 8, 2017
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P160017

Device type

Device class
Class III

Every decision under product code OZP

FDA's approval statement

As written in FDA's record.

Approval for 1) minor design changes to the electronics board stack used in the 670G insulin pump; 2) a new supplier for the electronics board stack; 3) an updated pump software version; and 4) an extension to the 670G insulin pump shelf life from 185 days to 1095 days.

Source documents

Other decisions for Medtronic Minimed, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.